Softgel Capsules Market

By Type;

Gelatin Type , Non-Animal Type , Gelatin Capsule and Non- Animal Capsule

By Source;

Porcine and Bovine

By Application;

Supplement, Nutrition, Vitamins, Supplement and Nutrition

By Distribution Channel;

Supermarkets & Hypermarkets, Pharmacies & Drug Stores and Online Providers

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn106361100 Published Date: August, 2025 Updated Date: September, 2025

Softgel Capsule Market Overview

Softgel Capsule Market (USD Million)

Softgel Capsule Market was valued at USD 7,291.03 million in the year 2024. The size of this market is expected to increase to USD 11,442.34 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.7%.


Softgel Capsules Market

*Market size in USD million

CAGR 6.7 %


Study Period2025 - 2031
Base Year2024
CAGR (%)6.7 %
Market Size (2024)USD 7,291.03 Million
Market Size (2031)USD 11,442.34 Million
Market ConcentrationMedium
Report Pages310
7,291.03
2024
11,442.34
2031

Major Players

  • Catalent, Inc
  • Patheon (Part Of Thermo Fisher Scientific)
  • Capsugel (A Part Of Lonza)
  • Captek Softgel International Inc
  • EuroCaps Ltd. (Part Of The DCC Plc Group)
  • Amway, Sirio Pharma Co. Ltd.
  • Strides Pharma Science Limited
  • International Vitamin Corporation, Soft Gel Technologies, Inc
  • Weihai Baihe Biology Technological Co. Ltd
  • China Shineway Pharmaceutical Group Limited
  • Yuwang Group
  • Guangdong Yichao Biological Co. Ltd

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Softgel Capsules Market

Fragmented - Highly competitive market without dominant players


The Softgel Capsules Market is expanding rapidly due to their high bioavailability, ease of consumption, and faster absorption compared to conventional dosage forms. Nearly 70% of consumers now prefer softgels over tablets and hard capsules, as they offer better swallowing comfort and more efficient nutrient delivery. This growing preference highlights their pivotal role in both pharmaceuticals and nutraceuticals.

Advantages Over Conventional Dosage Forms
Softgels are recognized for their improved drug solubility and enhanced stability, making them a superior choice for many formulations. Research suggests that about 60% of poorly soluble drugs show better absorption when delivered in softgel form. Their tamper-resistant nature and extended shelf life also build consumer trust, supporting strong adoption in healthcare applications.

Consumer Health and Wellness Trends
Increasing awareness around preventive healthcare is accelerating the demand for softgel capsules. Nearly 55% of supplement users opt for softgels as they effectively encapsulate vitamins, herbal extracts, and oils without reducing potency. Their convenience and effectiveness are reshaping consumer buying patterns and fueling continuous market growth.

Innovation in Formulation Technologies
Technological progress is further driving adoption, with more than 45% of manufacturers investing in advanced encapsulation and enteric coating techniques. These innovations enable controlled release, better bioavailability, and reduced gastrointestinal irritation. Such advancements are broadening the application scope of softgels across complex therapeutic areas.

Growing Demand in Pharmaceutical Applications
The pharmaceutical segment dominates, representing over 65% of total usage of softgel capsules. They are widely used in oncology, cardiovascular care, and pain management due to their controlled-release properties. As prescriptions and over-the-counter medications increasingly adopt softgels, their role in modern healthcare delivery continues to strengthen.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By Source
    3. Market Snapshot, By Application
    4. Market Snapshot, By Distribution Channel
    5. Market Snapshot, By Region
  4. Softgel Capsule Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Accurate dosing
        2. Protects ingredients from degradation
      2. Restraints
        1. High Cost of Raw Materials
        2. High cost of treatment
      3. Opportunities
        1. Personalization & Customization
        2. Vegan & Vegetarian Softgels
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry

  5. Market Segmentation
    1. Softgel Capsule Market, By Type, 2021 - 2031 (USD Million)
      1. Gelatin Type
      2. Non-Animal Type
      3. Gelatin Capsule
      4. Non- Animal Capsule
    2. Softgel Capsule Market, By Source, 2021 - 2031 (USD Million)

      1. Porcine

      2. Bovine

    3. Softgel Capsule Market, By Application, 2021 - 2031 (USD Million)
      1. Supplement
      2. Nutrition
      3. Vitamins
      4. Supplement
      5. Nutrition
    4. Softgel Capsule Market, By Distribution Channel, 2021 - 2031 (USD Million)

      1. Supermarkets & Hypermarkets

      2. Pharmacies & Drug Stores

      3. Online Providers

    5. Softgel Capsule Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Catalent, Inc
      2. Patheon (Part Of Thermo Fisher Scientific)
      3. Capsugel (A Part Of Lonza)
      4. Captek Softgel International Inc
      5. EuroCaps Ltd. (Part Of The DCC Plc Group)
      6. Amway
      7. Sirio Pharma Co. Ltd
      8. Strides Pharma Science Limited
      9. International Vitamin Corporation
      10. Soft Gel Technologies, Inc
      11. Weihai Baihe Biology Technological Co. Ltd
      12. China Shineway Pharmaceutical Group Limited
      13. Yuwang Group
      14. Guangdong Yichao Biological Co. Ltd.
  7. Analyst Views
  8. Future Outlook of the Market